drugset / Trial / NCT02693028

Lactobacillus Reuteri Feasibility Study on Probiotic Treatment and Perinatal Microbiome

NCT02693028

RandomizedParallel-groupQuadruple-blindBasic science

Summary

Investigators want to investigate if the Lactobacillus Reuteri (probiotic bacteria) given to pregnant women can be found in different maternal compartments and in the first stool and oral swab collected immediately after birth of a newborn delivered by cesarean delivery. Investigators also want to explore if exposure to this Lactobacillus Reuteri alters the level of inflammation in different compartments of the mother and the infant.

Timeline

Start
2015-11
Primary completion
2018-01
Completion
2018-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactobacillus reuteri Other / unclassified Oral

Indications